Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-06

Clinical Trial Update: Trial to Determine the Therapeutic Benefit of an OTC Cream on Dry, Itchy Skin of Adults and Children With Eczema [Phase 2]

View source ↗

Summary

Johnson & Johnson Consumer Inc. completed a Phase 2 trial evaluating an over-the-counter cream for dry, itchy skin in adults and children with atopic dermatitis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OTC eczema cream (unlisted)

Snippet

Sponsor: Johnson & Johnson Consumer Inc. (J&JCI) | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2017-03-06